Anzahl der Einträge: 6.
2012
Beckers, Thomas,
Mahboobi, Siavosh,
Sellmer, Andreas,
Winkler, Matthias,
Eichhorn, Emerich,
Pongratz, Herwig,
Maier, Thomas,
Ciossek, Thomas,
Baer, Thomas,
Kelter, Gerhard,
Fiebig, Heinz-Herbert und
Schmidt, Mathias
(2012)
Chimerically designed HDAC- and tyrosine kinase inhibitors. A series of erlotinib hybrids as dual-selective inhibitors of EGFR, HER2 and histone deacetylases.
MedChemComm 3 (7), S. 829.
Volltext nicht vorhanden.
2010
Mahboobi, Siavosh,
Sellmer, Andreas,
Winkler, Matthias,
Eichhorn, Emerich,
Pongratz, Herwig,
Ciossek, Thomas,
Baer, Thomas,
Maier, Thomas und
Beckers, Thomas
(2010)
Novel Chimeric Histone Deacetylase Inhibitors: A Series of Lapatinib Hybrides as Potent Inhibitors of Epidermal Growth Factor Receptor (EGFR), Human Epidermal Growth Factor Receptor 2 (HER2), and Histone Deacetylase Activity.
Journal of Medicinal Chemistry 53 (24), S. 8546-8555.
Volltext nicht vorhanden.
2009
Mahboobi, Siavosh,
Dove, Stefan,
Sellmer, Andreas,
Winkler, Matthias,
Eichhorn, Emerich,
Pongratz, Herwig,
Ciossek, Thomas,
Baer, Thomas,
Maier, Thomas und
Beckers, Thomas
(2009)
Design of chimeric histone deacetylase- and tyrosine kinase-inhibitors: a series of imatinib hybrides as potent inhibitors of wild-type and mutant BCR-ABL, PDGF-Rbeta, and histone deacetylases.
Journal of medicinal chemistry 52 (8), S. 2265-79.
Volltext nicht vorhanden.
2007
Mahboobi, Siavosh,
Sellmer, Andreas,
Höcher, Heymo,
Garhammer, Christian,
Pongratz, Herwig,
Maier, Thomas,
Ciossek, Thomas und
Beckers, Thomas
(2007)
2-Aroylindoles and 2-Aroylbenzofurans with N-Hydroxyacrylamide Substructures as a Novel Series of Rationally Designed Histone Deacetylase Inhibitors.
Journal of Medicinal Chemistry 50 (18), S. 4405-4418.
Volltext nicht vorhanden.
2006
2000
Diese Liste wurde erzeugt am Thu Jan 9 20:14:48 2025 CET.